BioCentury
ARTICLE | Company News

UMMS, Spark Therapeutics deal

October 31, 2016 7:00 AM UTC

Spark and the university will evaluate adeno-associated virus (AAV) vectors from a library of the university’s AAV capsids. Spark said the vectors may improve the delivery of gene therapies against di...